Request Demo
Last update 09 May 2025
Monoclonal Antibody E2.3(NCI)
Last update 09 May 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms monoclonal antibody E2.3(NCI) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Monoclonal Antibody E2.3(NCI)NCT00003082
A Phase IA Trial of Combined Murine IgG Monoclonal Anti-Transferrin Receptor Antibodies E2.3 and A27.15 in Cancer Patients
100 Clinical Results associated with Monoclonal Antibody E2.3(NCI)
Login to view more data
100 Translational Medicine associated with Monoclonal Antibody E2.3(NCI)
Login to view more data
100 Patents (Medical) associated with Monoclonal Antibody E2.3(NCI)
Login to view more data
100 Deals associated with Monoclonal Antibody E2.3(NCI)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced cancer | Phase 1 | United States | 01 Dec 1997 | |
| Leukemia | Phase 1 | United States | 01 Dec 1997 | |
| Multiple Myeloma | Phase 1 | United States | 01 Dec 1997 | |
| Myelodysplastic Syndromes | Phase 1 | United States | 01 Dec 1997 | |
| Myeloproliferative Disorders | Phase 1 | United States | 01 Dec 1997 | |
| Precancerous Conditions | Phase 1 | United States | 01 Dec 1997 | |
| Solid tumor | Phase 1 | United States | 01 Dec 1997 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free